Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer

Direct Puncture ◽

CYTOREDUCTIVE SURGERY (CRS) AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) IN PATIENTS WITH ADVANCED OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER: OUR EXPERIENCE IN 108 PATIENTS

10.26226/morressier.5d2ee8eb1e09a6f49485abf9 ◽

2019 ◽

Author(s):

Mihai Emil Capilna ◽

MIHAI GHEORGHE ◽

Szilard Leo Kiss ◽

Alexandra Lavinia Cozlea

Keyword(s):

Fallopian Tube ◽

Cytoreductive Surgery ◽

292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients

10.1136/ijgc-2019-igcs.292 ◽

2019 ◽

Author(s):

ME Capilna ◽

B Moldovan ◽

C Rad ◽

AA Moldovan ◽

AL Cozlea ◽

...

Keyword(s):

Fallopian Tube ◽

Cytoreductive Surgery ◽

EP811 A retrospective study regarding the role of cytoreductive surgery (CRS) and hypertermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer

10.1136/ijgc-2019-esgo.861 ◽

2019 ◽

Author(s):

ME Capilna ◽

B Moldovan ◽

C Rad ◽

AA Moldovan ◽

AL Cozlea

Keyword(s):

Retrospective Study ◽

Fallopian Tube ◽

Cytoreductive Surgery ◽

A phase II randomized study: Outcomes after cytoreductive surgery (CRS) with or without carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) followed by adjuvant chemotherapy as initial treatment of advanced stage (stage III/IV) ovarian, fallopian tube, and primary peritoneal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e17080 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e17080-e17080

Author(s):

Teresa Diaz-Montes ◽

Michelle Sittig ◽

Hyung Ryu ◽

Vadim Gushchin ◽

Armando Sardi

Keyword(s):

Adjuvant Chemotherapy ◽

Fallopian Tube ◽

Cytoreductive Surgery ◽

Initial Treatment ◽

Randomized Study ◽

Advanced Stage ◽

Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020)

Journal of Gynecologic Oncology ◽

10.3802/jgo.2022.33.e1 ◽

2022 ◽

Vol 33 ◽

Author(s):

Rhonda Farrell ◽

Michael Burling ◽

Yeh Chen Lee ◽

Selvan Pather ◽

Kristy Robledo ◽

...

Keyword(s):

Clinical Trial ◽

Fallopian Tube ◽

Cytoreductive Surgery ◽

Stage Iii ◽

Trial Protocol ◽

Clinical Trial Protocol ◽

Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.10.028 ◽

2009 ◽

Vol 112 (3) ◽

pp. 444-449 ◽

Cited By ~ 28

Author(s):

Amy D. Tiersten ◽

P.Y. Liu ◽

Harriet O. Smith ◽

Sharon P. Wilczynski ◽

William R. Robinson ◽

...

Keyword(s):

Neoadjuvant Chemotherapy ◽

Fallopian Tube ◽

Phase Ii ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Peritoneal Cancer ◽

Southwest Oncology Group Study

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as initial treatment of ovarian, fallopian tube, and primary peritoneal cancer: Preliminary results of a phase II randomized clinical trial

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.04.079 ◽

2018 ◽

Vol 149 ◽

pp. 35

Author(s):

T.P. Diaz-Montes ◽

F. El-Sharkawy ◽

V. Gushchin ◽

H.S. Ryu ◽

M. Sittig ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Fallopian Tube ◽

Phase Ii ◽

Cytoreductive Surgery ◽

Initial Treatment ◽

Improved Optimal Cytoreduction Rates for Stages IIIC and IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: A Change in Surgical Approach

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70606-4 ◽

2006 ◽

Vol 2006 ◽

pp. 466-467

Author(s):

G. Rodriguez

Keyword(s):

Fallopian Tube ◽

Surgical Approach ◽

Optimal Cytoreduction ◽

PREDICTING OUTCOME IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER ACCORDING TO HISTOLOGICAL TUMOUR RESPONSE TO NEO-ADJUVANT CHEMOTHERAPY, AT THE TIME OF INTERVAL DEBULKING.

10.26226/morressier.5770e29cd462b80290b4c049 ◽

2016 ◽

Author(s):

Sinead Barry

Keyword(s):

Adjuvant Chemotherapy ◽

Fallopian Tube ◽

Tumour Response ◽

Peritoneal Cancer ◽

Predicting Outcome ◽

Neo Adjuvant Chemotherapy

Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Case Medical Research ◽

10.31525/ct1-nct03907527 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Fallopian Tube ◽

Immune Cells ◽

Peritoneal Cancer ◽

Car T Cells ◽

Platinum Resistant ◽

Car T